Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N(C1CCN(CC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=POQDXIFVWVZVML-UHFFFAOYSA-N
InChI=1S/C21H26N2O/c1-2-21(24)23(19-11-7-4-8-12-19)20-13-15-22(16-14-20)17-18-9-5-3-6-10-18/h3-12,20H,2,13-17H2,1H3
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57 Gene ID: 4988.0 Gene Symbol: OPRM1 Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB09182 |
213.0 nM [Ki] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:01:26 GMT 2025
by
admin
on
Mon Mar 31 19:01:26 GMT 2025
|
| Record UNII |
9BV2D1A57H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
||
|
DEA NO. |
8334
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BENZYLFENTANYL
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
1474-02-8
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
9BV2D1A57H
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
DTXSID00163705
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
BENZYLFENTANYL
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | Benzylfentanyl has a Ki of 213nM at the mu opioid receptor, binding around 200x less strongly than fentanyl itself. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. | ||
|
DB09182
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
252141
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
73402
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY | |||
|
216-014-7
Created by
admin on Mon Mar 31 19:01:26 GMT 2025 , Edited by admin on Mon Mar 31 19:01:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|